Heart Failure Clinical Trial

Clinical Trial Finder Heart Failure Trials

Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure

See Locations Near You

Summary

This is a randomized, double-blind, placebo-controlled, dose ranging pilot study to examine the effects of conivaptan in patients with acute decompensated heart failure.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients may be male or female age 18 years or older.
Women must be post-menopausal or surgically sterile.
Patients must have chronic heart failure of at least 2 months duration and be hospitalized for the treatment of worsening heart failure. The primary manifestation of worsening heart failure must be worsening dyspnea.

Study is for people with:

Heart Failure

Phase:

Phase 2

Estimated Enrollment:

170

Study ID:

NCT00057356

Recruitment Status:

Completed

Sponsor:

Cumberland Pharmaceuticals

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 26 Locations for this study

See Locations Near You

The Heart Center, P.C.
Huntsville Alabama, 35801, United States
LA County/USC Medical Center
Los Angeles California, 90033, United States
San Joaquin Cardiology
Manteca California, 95337, United States
Apex Research Institute
Santa Ana California, 92705, United States
The Greater Fort Lauderdale Heart Group Research
Fort Lauderdale Florida, 33308, United States
Jacksonville Center for Clinical Research
Jacksonville Florida, 32216, United States
U. Miami, Jackson Mem'l Medical Center
Miami Florida, 33136, United States
Discovery Medical Research Group
Ocala Florida, 34478, United States
Rush-Presbyterian St. Luke's Medical Center
Chicago Illinois, 60612, United States
Louisiana State University Medical Center School of Medicine
New Orleans Louisiana, 70112, United States
New Orleans Center for Clinical Research
New Orleans Louisiana, 70119, United States
Cardiac Centers of Louisiana, LLC
Shreveport Louisiana, 71103, United States
University of Maryland Hospital
Baltimore Maryland, 20201, United States
Hennepin County Medical Center
Minneapolis Minnesota, 55415, United States
Washington University
St. Louis Missouri, 63110, United States
Dartmouth-Hitchcock Medical Center
Lebanon New Hampshire, 03756, United States
New York Presbyterian Hosp, Milstein Hosp.
New York New York, 10032, United States
University of Cincinnati, College of Medicine, Div. of Cardiology
Cincinnati Ohio, 45267, United States
The Cleveland Clinic Foundation
Cleveland Ohio, 44195, United States
Ohio State University Medical Center, Heart and Lung Research Institute
Columbus Ohio, 43210, United States
Hershey Medical Center
Hershey Pennsylvania, 17033, United States
Medical University of South Carolina
Charleston South Carolina, 29425, United States
Baptist Clinical Research
Memphis Tennessee, 38120, United States
Cardiovascular Research Institute of Dallas
Dallas Texas, 75231, United States
Baylor College of Medicine
Houston Texas, 77030, United States
University of Washington
Seattle Washington, 98195, United States
Load More

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Phase:

Phase 2

Estimated Enrollment:

170

Study ID:

NCT00057356

Recruitment Status:

Completed

Sponsor:


Cumberland Pharmaceuticals

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider